The fourth mammalian molybdenum enzyme mARC: current state of research

Author： Havemeyer Antje   Lang Juliane   Clement Bernd  

Publisher： Informa Healthcare

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.43, Iss.4, 2011-11, pp. : 524-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 945-955

Bentham Science Publishers

Access to resources Recommend Favorite

Antivirals: current state of the art

By De Clercq Erik  

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 393-405

Future Medicine

Access to resources Recommend Favorite

Future of Low Specific Activity Molybdenum-99/Technetium-99m Generator

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 325-328

Bentham Science Publishers

Access to resources Recommend Favorite

Current trends in fibromyalgia research

By Marcus Dawn A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1687-1695

Informa Healthcare

Access to resources Recommend Favorite

Economic Statecraft and Foreign Policy: Sanctions, Incentives and Target State Calculations by Jean‐Marc F. Blanchard and Norrin M. Ripsman. Abingdon: Routledge, 2013. 266pp., £80.00, ISBN 9780415629935

By  

POLITICAL STUDIES REVIEW, Vol. 13, Iss. 2, 2015-05 ,pp. : 260-261

John Wiley & Sons Inc

Access to resources Recommend Favorite